EP 1917008 A2 20080507 - USE OF SOLUBLE GUANYLATE CYCLASE FOR THE TREATMENT OF RAYNAUD'S PHENOMENON
Title (en)
USE OF SOLUBLE GUANYLATE CYCLASE FOR THE TREATMENT OF RAYNAUD'S PHENOMENON
Title (de)
VERWENDUNG VON AKTIVATOREN DER LÖSLICHEN GUANYLATZYKLASE ZUR BEHANDLUNG VON RAYNAUD PHÄNOMENEN
Title (fr)
UTILISATION D'ACTIVATEURS DE LA GUANYLATE CYCLASE SOLUBLE POUR TRAITER LES PHENOMENES DE RAYNAUD
Publication
Application
Priority
- EP 2006006501 W 20060704
- DE 102005033370 A 20050716
- DE 102005047945 A 20051006
Abstract (en)
[origin: CA2615051A1] The invention relates to the use of compounds of formulae (I-VI) for the production of a medicament for the treatment of primary and secondary Raynaud's phenomenon.
IPC 8 full level
A61K 31/194 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61P 9/08 (2006.01)
CPC (source: EP US)
A61K 31/194 (2013.01 - EP US); A61K 31/506 (2013.01 - EP US); A61K 31/5377 (2013.01 - EP US); A61P 7/00 (2017.12 - EP); A61P 9/08 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2007009589A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
DE 102005047945 A1 20070118; CA 2615051 A1 20070125; EP 1917008 A2 20080507; JP 2009501737 A 20090122; US 2009215769 A1 20090827; WO 2007009589 A2 20070125; WO 2007009589 A3 20070816
DOCDB simple family (application)
DE 102005047945 A 20051006; CA 2615051 A 20060704; EP 06762392 A 20060704; EP 2006006501 W 20060704; JP 2008521831 A 20060704; US 98899106 A 20060704